DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 1.59% to $784.36 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.62% to 7,757.64 and the Dow Jones Industrial Average rising 0.28% to 54,036.93.
This was the stock's fourth consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 4.48% below its 52-week high of $821.11, which the company achieved on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.51% to $410.95, Moderna Inc. (MRNA) rose 9.86% to $59.17, and Gilead Sciences Inc. (GILD) rose 1.80% to $133.21.
Trading volume (716,514) remained 267,470 below its 50-day average volume of 983,984.
Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.